Normal tissue response to low doses of radiotherapy assessed by molecular markers: A study of skin in patients treated for prostate cancer

Acta Oncologica

Volumn 40, Issue 8, 2001, Pages 941-951

  Turesson, Ingela ^a   Bernefors, Ragnhild ^a   Book, Majlis ^a   Flogegård, Max ^a   Hermansson, Ingegerd ^a   Johansson, Karl Axel ^a   Lindh, Anna ^a   Sigurdardottir, Sunna ^a   Thunberg, Ulf ^a   Nyman, Jan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DNA; IONIZING RADIATION; MOLECULAR BIOLOGY; PROTEINS; RADIOTHERAPY; SKIN;

MOLECULAR MARKERS;

TISSUE;

KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; CANCER RADIOTHERAPY; CONFERENCE PAPER; DNA DAMAGE; HUMAN; HUMAN TISSUE; IONIZING RADIATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION HAZARD; SKIN BIOPSY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BIOPSY; DNA DAMAGE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); RADIATION INJURIES; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035698469     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860152708224     Document Type: Conference Paper

References (89)

1. Conformal radiotherapy and intensity-modulated radiotherapy - Clinical data
2. Clinical evidence of hypersensitivity to low doses in radiotherapy
3. The response of Chinese hamster V79 cells to low radiation doses: Evidence of enhanced sensitivity of the whole cell population
4. Might intrinsic radioresistance of human tumour cells be induced by radiation?
5. Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells
6. Adaptive response and induced resistance
7. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity
8. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the 'adaptive response' and cannot be explained by a subpopulation of sensitive cells
9. Evidence for two forms of substructure in the cell survival curve - Mechanisms and clinical consequences
10. Low-dose hypersensitivity: Current status and possible mechanisms
11. Low-dose hypersensitivity after fractionated low-dose irradiation in vitro
12. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin
13. Renal damage in the mouse: The response to very small doses per fraction
14. The linear quadratic fit for lung function after irradiation with x-rays at smaller doses per fraction than 2 Gy
15. A novel human stress response-related gene with a potential role in induced radioresistance
16. Modification of survival by DNA repair modifiers: A probable explanation for the phenomenon of increased radioresistance
17. Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, acceleration of stem-cell divisions and abortive divisions
18. The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation
19. Repopulation in mouse oral mucosa: Changes in the effect of dose fractionation
20. The proliferation-associated Ki-67 protein: Definition in molecular terms
21. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1
22. p53 and ATM: Cell cycle, cell death, and cancer
23. Regulation of p53 downstream genes
24. Induction of stress genes by low doses of gamma rays
25. The p53 pathway
26. Signaling to p53: Breaking the posttranslational modification code
27. Stress signals utilize multiple pathways to stabilize p53
28. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest
29. Enhanced phosphorylation of p53 by ATM in response to DNA damage
30. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
31. Ionizing radiation activates the ATM kinase throughout the cell cycle
32. DNA-PK, ATM and ATR as sensors of DNA damage: Variations on a theme?
33. Rapid radiation-induction of ATM protein levels in situ
34. ATM and ATR: Networking cellular responses to DNA damage
35. Cellular senescence: Mitotic clock or culture shock?
36. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
37. Surfing the p53 network
38. Regulation and function of the p53 tumor suppressor protein
39. Regulation of p53 function
40. The ARF/p53 pathway
41. Parsing Ink4a/Arf: 'pure' p16-null mice
42. The ink4a/arf network in tumour suppression
43. p53, the cellular gatekeeper for growth and division
44. Requirement for p53 and p21 to sustain G2 arrest after DNA damage
45. Transcriptional regulation of the p21((WAF1/CIP1)) gene
46. p21(WAF1/Cipl): More than a break to the cell cycle?
47. The Pezcoller lecture: Cancer cell cycles revisited
48. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
49. p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential
50. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
51. Mechanisms of p53-mediated apoptosis
52. The p53 pathway and apoptosis
53. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling
54. p53: Death star
55. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo
56. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
57. Epidermal stem cells: Markers, patterning and the control of stem cell fate
58. Stem cell fate and patterning in mammalian epidermis
59. Basal cell density in human skin for various fractionation schedules in radiotherapy
60. Ki-67 immunostaining of normal human epidermis: Comparison with 3H-thymidine labelling and PCNA immunostaining
61. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis
62. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: Immunohistochemical characterization
63. Quantitative analysis of the proliferation of epidermal cells using a human skin organ culture system and the effect of DbcAMP using markers of proliferation (BrdU, Ki-67, PCNA)
64. Changes in the rate of repopulation during multifraction irradiation of mouse skin
65. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses
66. The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine
67. Repopulation of mouse jejunal crypt cells
68. Proliferation equivalent of 'accelerated repopulation' in mouse oral mucosa
69. Epidermal morphology, cell proliferation and repopulation in mouse skin during daily fractionated irradiation
70. The proliferative response of mouse jejunal crypt cells to radiation-induced cell depletion is not mediated exclusively by transforming growth factor alpha
71. Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial
72. The hazard of accelerated tumor clonogen repopulation during radiotherapy
73. Biological factors influencing optimum fractionation in radiation therapy
74. Rapid repopulation in radiotherapy: A debate on mechanism. Accelerated repopulation in tumours and normal tissues
75. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes
76. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis
77. The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: A new view based on whole-mount labelling and lineage analysis
78. Persistent p53 mutations in single cells from normal human skin
79. Induction of p53 expression in skin by radiotherapy and UV radiation: A randomized study
80. Defying death after DNA damage
81. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
82. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
83. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53
84. Different impact of p53 and p21 on the radiation response of mouse tissues
85. Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size
86. Diminished cell proliferation associated with the death-protective activity of Bcl-2
87. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation
88. TGF beta signaling and cancer
89. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation